Pharmaceuticals, Biotechnology and Life Sciences
Basel, Switzerland, April 21, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that shareholders approved all proposals of the board…
Several major clinical milestones achieved in 2020 by AsiDNA™, including promising initial results in combination with chemotherapy and the launch…
Opening of Investigational New Drug Application (IND) with U.S. Food and Drug Administration (FDA) for Phase III study of nomacopan…
LEXINGTON, Mass., April 20, 2021 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing…
Saint-Herblain (France), April 20, 2021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic…
BOSTON, April 20, 2021 (GLOBE NEWSWIRE) — Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter…
MARLBOROUGH, Mass., April 20, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…
REDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused…
Eddie L. Varnado joins Lumos Pharma as Vice President, Finance and Corporate ControllerAUSTIN, Texas, April 20, 2021 (GLOBE NEWSWIRE) —…
NASHVILLE, Tenn., April 20, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused…